Adoptively Transferred Expanded Natural Killer Cells Inhibit Myeloma Tumor Growth In Vivo

被引：0

作者：

Garg, Tarun K. ^{[1
]}

Szmania, Susann ^{[1
]}

Malbrough, Paul ^{[1
]}

Ekworomadu, Charles ^{[1
]}

Stone, Katie ^{[1
]}

Moreno-Bost, Amberly ^{[1
]}

Woods, Emily ^{[1
]}

Shi, Jumei ^{[2
]}

Yaccoby, Shmuel ^{[1
]}

Shaughnessy, John D., Jr. ^{[1
]}

Barlogie, Bart ^{[1
]}

Campana, Dario ^{[3
]}

van Rhee, Frits ^{[1
]}

机构：

[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA

[2] Tongji Univ, Shanghai Peoples Hosp 10, Dept Hematol, Shanghai 200092, Peoples R China

[3] St Jude Childrens Hosp, Memphis, TN 38105 USA

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：393 / 394

页数：2

共 50 条

[11] Characterizing the anti-tumor function of adoptively transferred NK cells in vivo
Pegram, Hollie J.
Haynes, Nicole M.
Smyth, Mark J.
Kershaw, Michael H.
Darcy, Phillip K.
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (08) : 1235 - 1246
[12] Ex vivo expanded autologous natural killer cells as a novel therapeutic approach in multiple myeloma
Alici, Evren
Sutlu, Tolga
Bjokstrand, Bo
Gilljam, Mari
Stellan, Birgitta
Nahi, Hareth
Quezada, Hernan Concha
Gahrton, Gosta
Ljunggren, Hans-Gustaf
Dilber, M. Sirac
HUMAN GENE THERAPY, 2008, 19 (10) : 1183 - 1183
[13] A Phase I Trial of Adoptively Transferred Ex-Vivo Expanded Autologous Natural Killer (NK) Cells Following Treatment with Bortezomib to Sensitize Tumors to NK Cell Cytotoxicity
Reger, Robert N.
Berg, Maria
Lundqvist, Andreas
Donohue, Theresa
Carlsten, Mattias
Betters, Dawn M.
Cook, Lisa
Ramos, Catalina
Grasmeder, Sophia
Su, Su
Stroncek, David
Pantin, Jeremy
Keyvanfar, Keyvan
Carvallo, Cristian A.
Khuu, Hahn
Childs, Richard
BLOOD, 2011, 118 (21) : 457 - 458
[14] In vivo trafficking of adoptively transferred dendritic cells.
Geskin, LJ
Celluzzi, CM
Falo, LD
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 438 - 438
[15] Carfilzomib combined with ex vivo-expanded patient autologous natural killer cells for myeloma immunotherapy
Chang, S. K.
Hou, J.
Chen, G. G.
Yu, D. D.
Wu, H. Q.
Xie, Y. S.
Hu, L. N.
Gao, L.
Xiao, W. Q.
Kong, Y. Y.
Tao, Y.
Shi, J. M.
NEOPLASMA, 2018, 65 (05) : 720 - 729
[16] ACTIVATED AND EXPANDED NATURAL KILLER CELLS FROM MULTIPLE MYELOMA PATIENTS DESTROY TUMOR DRUG RESISTANT CELLS AND CLONOGENIC TUMOR CELLS
Leivas, A.
Rapado, I.
Fernandez, L.
Perez-Martinez, A.
Lahuerta, J. J.
Martinez-Lopez, J.
HAEMATOLOGICA, 2017, 102 : 505 - 506
[17] Treatment of subcutaneous tumor with adoptively transferred T cells
Peng, LM
Shu, SY
Krauss, JC
CELLULAR IMMUNOLOGY, 1997, 178 (01) : 24 - 32
[18] Enhancing Trafficking of Adoptively Transferred Natural Killer Cells Via Prostaglandin E2 Signaling
Otegbeye, Folashade
Moreton, Stephen
Ojo, Evelyn
Mackowski, Nathan
Desai, Amar
Markowitz, Sanford
Wald, David
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S477 - S478
[19] SELECTIVE ACCUMULATION OF ADOPTIVELY TRANSFERRED KILLER-CELLS IN LUNG METASTASES
BASSE, PH
HOKLAND, M
HERBERMAN, RB
WASSERMAN, K
GOLDFARB, RH
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (04) : 623 - 623
[20] EFFECT OF THE IMIDS ON NATURAL KILLER CELLS ACTIVATED AND EXPANDED IN MULTIPLE MYELOMA
Leivas, A.
Ramilo, P.
Guzman, A.
Valeri, A.
Garcia-Ortiz, A.
Rivero, A.
Martinez-Lopez, J.
HAEMATOLOGICA, 2018, 103 : 193 - 194

← 1 2 3 4 5 →